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Summary 
Old and young adult rats received unilateral injections of MPTP or saline into 
the substantia nigra. Unilateral injection of MPTP in old rats induced 
ipsiversive circling on day 1 and day 7 after the injection; contraversive 
circling behavior was induced in MPTP-treated rats by systemic 
administration of apomorphine. Young rats showed ipsiversive circling on 
day 1 but not on day 7 after the injection; administration of apomorphine did 
not induce contraversive circling. On day 10 after the injection of MPTP, the 
concentration of D-2 receptors in the striatum of the injected hemisphere of 
old rats was increased by about 25 % compared with the striatum of old rats 
with saline injection and of young rats with MPTP or saline injections. These 
results suggest that MPTP exerts neurotoxic effects on the nigrostriatal 
dopaminergic system of old rats and produces supersensitive dopamine 
receptors in the ipsilateral denervated striatum. 
1-Methyl-4-phenyl-1,2,3,6_tetrahydropyridine (MPTP) causes destruction of dopaminergic 
neurons in the substantia nigra pars compacta in humans and non-human primates and induces 
an irreversible syndrome with behavioral, neurochemical and histopathological changes similar 
to idiopathic Parkinson’s disease (l-3). The brains of rodents, especially of rats, are more 
resistant to the neurotoxicity of MPTP than the brains of primates. Initial attempts to induce 
pathological effects in rats by systemic administration of MPTP were not successful (4,5). 
Intranigral injection of MPTP in the rat failed to produce lasting damage to the dopaminergic 
nigral neurons ($6) or lasting behavioral effects (7). 
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Evidence is evolving that the neurotoxic effects of MPTP are age-dependent. While MPTP 
does little damage to neurons in the young mature mouse, it does have severe effects in the old 
mouse on both visible signs of movement disability and anatomical damage to the substantia 
nigra (8). The present study attempted to determine the behavioral effects of unilateral injection 
of MPTP into the substantia nigra in old rats in comparison with young adult rats. 
Circling was the behavioral model used for the assessment of dopaminergic lesions in the 
substantia nigra. Circling behavior in the rat can be produced by destruction of one ascending 
nigrostriatal dopamine pathway and is believed to reflect an imbalance of dopaminergic activity 
in the striata. The rat turns towards the side of the lesion, i.e. away from the hemisphere of 
higher striatal dopaminergic activity. After systemic administration of dopamine agonists circling 
away from the hemisphere with destroyed nigrostriatal pathway appears due to supersensitivity 
of the denervated striatal dopamine receptors (9,lO). 
Materials and Methods 
Male BD IX rats had chronic guide cannulae implanted to allow unilateral injection into the 
substantia nigra. The guide cannulae were unilaterally implanted 2.0 mm dorsal to the substantia 
nigra under equithesin anesthesia using a stereotaxic instrument (David Kopf Instruments, Palo 
Alto, CA). Young adult rats aged 4 to 5 months (N = 6) and old rats aged 22 to 24 months (N = 
7) received a unilateral injection of 50 p&l ~1 MPTP (Research Biochemicals Inc., Wayland, 
MA) through an inner injection cannula which extended 2.0 mm beyond the end of the guide 
cannula. MPTP was injected over a period of 5 minutes; the injection cannula was left in place 
for an additional 60 seconds following the injection to ensure adequate diffusion and to minimize 
spread of solution up through the cannula tract. Young adult (N = 6) and old control rats (N = 7) 
received a saline solution which was equimolar to the MPTP solution. The stereotaxic 
coordinates for the intranigral injection corresponded to Konig and Klippel (11) coordinates: A 
2420, V -2.4, L 1.6. 
Circling behavior in both groups was automatically recorded with the animals in a square 
box (0.5 x 0.5 m). The number of rotations directed either ipsiversive or contraversive with 
respect o the injected hemisphere were measured. Recordings were made for 30 minutes on day 
1 following intranigral injection and on day 7 for 30 minutes before and for 30 minutes after 
subcutaneous injection of apomorphine (0.5 mg/kg body weight; Woelm Pharma, Eschwege, 
F.R.G.). 
On day 10 after injection of MPTP or saline, rats were killed by cervical dislocation and 
decapitation and the brains rapidly removed onto ice. The striatum was dissected out and placed 
into ice-cold 50 mM Tris-HCl buffer (pH 7.6). Specific binding of [3H]spiperone (Amersham 
International, U.K.; 18-19 Ci/mmol; concentrations between 0.1 and 1.0 nM) in tissue 
homogenates of the striatum of the injected hemisphere was determined by the method of Leysen 
et al. (12), in a final tissue suspension of 1 in 800 w/v using an incubation buffer containing 50 
mM Tris-HCl and 120 mM NaCl (pH 7.6). Nonspecific binding of [3H]spiperone was defined 
by the incorporation of 10e5 M (+)-sulpiride (Delagrange, Paris, France). All determinations 
were carried out in triplicate. The number of binding sites (Bmax ) and the apparent equilibrium 
constant (Kd) were determined by Eadie-Hofstee analysis. 
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FIGURE 1 
Ipsiversive (IPSI) and contraversive (CONTRA) circling 1 day and 7 days after 
unilateral injection of MPTP (black bars) or saline (white bars) into the substantia 
nigra of young adult and old rats and apomorphine-induced circling on day 7 after 
injection (means + s.e.m.). 
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Results A 
Unilateral intranigral injection of MPTP induced strong ipsiversive circling (i.e. towards 
the side of injection) in both young adult and old rats on the first day after injection (see fig. 2). 
On day 7 after the MPTP injection, spontaneous ipsiversive circling behavior was still present in 
old rats whereas young adult rats did not circle preferentially in either direction. Neither young 
adult nor old control rats showed asymmetry in circling behavior. Old rats with unilateral MPTP 
injections circled contraversively when injected with apomorphine 7 days after the injection; 
young adult rats did not show contraversive circling after administration of apomorphine (see 
fig. 1). 
Ten days after the unilateral intranigral injection of MPTP or saline, the concentration 
(Btnax) of striatal D-2 receptors identified by [sH]spiperone in the injected hemisphere of old rats 
with MPTP injection was substantially increased compared with the injected hemisphere of old 
rats with saline injection and of young rats with MPTP or saline injections (see fig. 2). The 
affinity (Kd) of D-2 receptors was not affected. 
YOUNG RATS OLD RATS 
FIGURE 2 
D-2 receptor densities (Btnax, means zL- s.e.m.) in the striatum of the injected 
hemisphere of young adult and old rats 10 days after unilateral intranigral injection 
of MPTP (black bars) or saline (white bars); in comparison with the control group: 
* p < 0.05, Mann-Whitney U-test. 
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Discussion 
In young adult rats unilateral injection of MPTP into the substantia nigra induced 
ipsiversive circling of short duration and after systemic administration of the dopamine agonist 
apomorphine the rats did not circle preferentially in either direction. Thus, MPTP has only a 
short lasting depressive effect on dopaminergic neurons in young rats. In old rats ipsiversive 
turning could be observed for at least one week after the injection of MPTP, the administration of 
apomorphine induced contraversive turning. D-2 receptor density in the striatum of the injected 
hemisphere was higher after MPTP injection than after saline injection. These results suggest 
that MPTP exerts neurotoxic actions on the nigrostriatal dopaminergic system of old rats and 
induces supersensitivity of the dopamine receptors in the denervated striatum on the side of 
MPTP injection. 
The present results suggest hat the effects of unilateral intranigral injection of MPTP are 
age-dependent and that previous attempts to induce lasting changes by MPTP in rats were 
unsuccessful because young animals were used. Other studies also provide evidence that the 
effects of MPTP increase with age. Neonatal rats are resistant o the dopamine-depleting effects 
of MPTP whereas the toxin produces a 65 % striatal dopamine depletion in young adult rats 
(13). Extensive degeneration of nigral neurons is found in older but not younger mice given 
MPTP (14). The ventral tegmental area and the locus coeruleus of old but not young mice are 
affected by MPTP (8); the distribution of lesions in older mice is much closer to the pathological 
changes seen in Parkinson’s disease. 
The neurotoxic effects of MPTP have been shown to be dependent on its conversion to 
l-methyl-4-phenylpyridine (MPP+) by monoamine oxidase B (MAO B; 15,16). The enhanced 
toxicity of MPTP in older animals can be due to increased sensitivity of nigrostriatal neurons of 
older animals to the effects of MPTP or to the presence of greater quantities of MPTP or its 
metabolite MPP+ in the target area. No differences in the striatal dopamine depletion induced by 
intracerebroventricular administration of MPP+ are observed between young and old mice (17), 
suggesting that old nigrostriatal neurons are not more sensitive to MPP+ and that higher 
concentrations of the toxin account for the age-related effects. Thus, in the present study the 
enhanced MPTP effects in older animals are likely to be the result of increased MPP+ 
concentrations in the substantia nigra. A possible explanation for the age-dependence of MPTP 
toxicity is the increase of MAO B activity in the brain with age. In the rat central MAO B activity 
increases at least over the first two years of life (18). In the mouse striatal MPPC concentrations 
increase directly with the age of the animals injected with MPTP (19). 
MPTP-induced neurotoxicity in animals, especially in primates, has provided a very useful 
model of Parkinson’s disease. Since Parkinson’s disease is an age-related neurodegenerative 
disorder usually occurring in the sixth or seventh decade of life, it might be interesting to further 
investigate the effects of MPTP in old rats and ascertain whether or not the old rat can be used as 
a model. 
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